Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Bulletin of the World Health Organization|January 24, 2007
A proposal for measuring the degree of public health-sensitivity of patent legislation in the context of the WTO TRIPS AgreementGabriela Costa Chaves, Maria Auxiliadora Oliveira
Cadernos De Saude Publica|April 11, 2015
[Induction of hospital indebtedness due to medicine purchases under monopoly conditions: the case of imatinib mesylate]Carolinne Thays Scopel, Gabriela Costa Chaves
Cadernos De Saude Publica|December 8, 2016
Initiatives to challenge patent barriers and their relationship with the price of medicines procured by the Brazilian Unified National Health SystemCarolinne Thays Scopel, Gabriela Costa Chaves
AIDS (London, England)|September 25, 2007
Sustaining access to antiretroviral therapy in the less-developed world: lessons from Brazil and ThailandNathan Ford, David Wilson, Gabriela Costa Chaves, et al.
Bulletin of the World Health Organization|January 11, 2005
Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?Maria Auxiliadora Oliveira, Jorge Antonio Zepeda Bermudez, Gabriela Costa Chaves, et al.
Ciencia & Saude Coletiva|August 10, 2017
Public procurement of hepatitis C medicines in Brazil from 2005 to 2015Gabriela Costa Chaves, Claudia Garcia Serpa Osorio de Castro, Maria Auxiliadora Oliveira
Cadernos De Saude Publica|January 16, 2007
[Evolution of the international intellectual property rights system: patent protection for the pharmaceutical industry and access to medicines]Gabriela Costa Chaves, Maria Auxiliadora Oliveira, Lia Hasenclever, et al.
Revista De Saude Publica|January 14, 2016
Strategies for price reduction of HIV medicines under a monopoly situation in BrazilGabriela Costa Chaves, Lia Hasenclever, Claudia Garcia Serpa Osorio-de-Castro, et al.
Cadernos De Saude Publica|September 25, 2007
[Uncomplicated Plasmodium vivax and P. falciparum malaria in Brazil: evidence on single and combined drug treatments recommended by official guidelines]Letícia Figueira Freitas, Gabriela Costa Chaves, Lenita Wannmacher, et al.
Ciencia & Saude Coletiva|August 10, 2017
National Medicines Policy in retrospective: a review of (almost) 20 years of implementationDaniela Moulin Maciel de Vasconcelos, Gabriela Costa Chaves, Thiago Botelho Azeredo, et al.
Pageof 2